Research News

Revealing Mitochondrial Secret to Cancer Therapy Resistance

New, collaborative work from researchers’ team led by Dr. Shruti Bhatt at National University of Singapore and Dr. Letai at Dana-Farber Cancer Institute has succeeded in understanding the biology of relapsed cancer cells by using mouse models of acute myeloid leukemia (AML), highly aggressive blood cancer.

Read more here: https://aacrjournals.org/bloodcancerdiscov/article-abstract/doi/10.1158/2643-3230.BCD-24-0001/735047/Acquired-Multidrug-Resistance-in-AML-Is-Caused-by?redirectedFrom=fulltext

 

 

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

New Book by Prof Goh Boon Cher & A/Prof Wang Lingzhi

We are pleased to share that Prof. Goh Boon Cher and A/Prof. Wang Lingzhi have published a new edited volume …

Read More →
Research News

New Hope for Treating Drug-Resistant Leukaemia

Acute myeloid leukaemia (AML) is a fast-growing blood cancer that often becomes resistant to standard treatments. This resistance is linked …

Read More →
Research News

Prospective Evaluation of QPOP in Relapsed/ Refractory Non-Hodgkin’s Lymphoma

Treatment of relapsed/refractory non-Hodgkin’s lymphoma (R/R-NHL) remains one of the most difficult challenges in haematologic malignancies, with many patients exhausting …

Read More →